ICU Medical (ICUI) Financials: History & Chart

ICU Medical, Inc.(ICUI)

Medical - Instruments & Supplies · San Clemente, CA

$158.01-3.39 (-2.10%)

Delayed quote: Oct 6, 2026, 2:50 PM EDT

About ICU Medical, Inc.

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

San Clemente, CA

13,000 employees

www.icumed.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Vivek Jain

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	2.16B	551.68M	530.37M	540.31M	536.99M	548.87M	604.70M	629.80M	589.13M
Cost of Goods Sold	1.35B	316.63M	357.28M	338.18M	336.11M	340.80M	394.59M	402.55M	384.28M
Gross Profit	811.16M	235.05M	173.10M	202.13M	200.88M	208.06M	210.11M	227.26M	204.85M
Gross Profit Margin	37.6%	42.6%	32.6%	37.4%	37.4%	37.9%	34.7%	36.1%	34.8%
Total Operating Expenses	702.40M	195.93M	142.42M	176.90M	187.16M	197.48M	197.22M	189.57M	196.62M
Research & Development	86.32M	22.70M	21.28M	21.09M	21.25M	21.87M	23.29M	22.36M	21.03M
Selling, General & Administrative	615.07M	151.92M	154.57M	155.81M	152.77M	159.39M	157.23M	158.85M	162.71M
Operating Income (EBIT)	108.75M	39.13M	30.68M	25.23M	13.72M	10.59M	12.89M	37.69M	8.24M
Operating Margin	5.0%	7.1%	5.8%	4.7%	2.6%	1.9%	2.1%	6.0%	1.4%
Income Before Tax (EBT)	-3.88M	23.14M	-4.58M	-18.39M	-4.05M	36.52M	-10.91M	8.22M	-17.93M
Interest Income	6.99M	2.81M	2.04M	2.14M	N/A	2.52M	3.23M	2.73M	2.60M
Interest Expense	82.95M	18.56M	19.75M	24.84M	19.81M	23.07M	29.02M	26.19M	27.29M
Other Income/Expense	-112.63M	-15.98M	-35.26M	-43.62M	-17.77M	25.93M	-23.79M	-29.47M	-26.16M
Net Income	30.09M	19.09M	30.13M	-15.73M	-3.40M	35.34M	-15.48M	-23.83M	-32.98M
Income Tax Expense	-30.95M	7.07M	-34.71M	-2.65M	-658K	1.18M	4.57M	32.05M	15.05M
Net Profit Margin	1.4%	3.5%	5.7%	-2.9%	-0.6%	6.4%	-2.6%	-3.8%	-5.6%
EBITDA	363.56M	138.77M	80.70M	79.57M	64.52M	60.25M	62.33M	90.70M	63.84M
EBITDA Margin	16.8%	25.2%	15.2%	14.7%	12.0%	11.0%	10.3%	14.4%	10.8%
Depreciation & Amortization	254.81M	99.64M	50.03M	54.34M	50.80M	49.66M	49.45M	53.01M	55.60M
EPS Basic	1.20	0.76	1.22	-0.64	-0.14	1.43	-0.63	-0.97	-1.35
EPS Diluted	1.18	0.76	1.20	-0.64	-0.14	1.43	-0.63	-0.97	-1.35
Weighted Average Basic Shares	25.00M	25.00M	24.76M	24.69M	24.69M	24.64M	24.54M	24.49M	24.44M
Weighted Average Diluted Shares	25.04M	25.04M	25.18M	24.69M	24.69M	24.71M	24.54M	24.49M	24.44M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	2.23B	2.38B	2.26B	2.28B	1.32B	1.27B	1.27B	1.40B
Cost of Goods Sold	1.41B	1.56B	1.52B	1.58B	824.82M	809.51M	794.34M	830.01M
Gross Profit	819.65M	824.78M	739.87M	697.76M	491.49M	461.50M	471.86M	570.03M
Gross Profit Margin	36.8%	34.6%	32.8%	30.6%	37.3%	36.3%	37.3%	40.7%
Total Operating Expenses	712.71M	781.82M	717.05M	740.66M	368.25M	363.33M	364.50M	381.01M
Research & Development	87.50M	88.61M	85.34M	92.98M	47.50M	42.95M	48.61M	52.87M
Selling, General & Administrative	625.21M	638.76M	606.69M	608.35M	302.58M	283.95M	276.98M	328.15M
Operating Income (EBIT)	106.95M	42.96M	22.82M	-42.90M	123.25M	98.16M	107.36M	21.61M
Operating Margin	4.8%	1.8%	1.0%	-1.9%	9.4%	7.7%	8.5%	1.5%
Income Before Tax (EBT)	3.17M	-66.01M	-78.30M	-114.41M	123.19M	97.49M	114.71M	22.37M
Interest Income	10.31M	10.79M	7.51M	4.43M	2.84M	3.68M	N/A	N/A
Interest Expense	105.38M	106.54M	102.73M	70.81M	858K	1.75M	549K	709K
Other Income/Expense	-103.78M	-108.98M	-101.12M	-71.51M	-59K	-668K	7.35M	-7.38M
Net Income	732K	-117.69M	-29.66M	-74.29M	103.14M	86.87M	101.03M	28.79M
Income Tax Expense	2.44M	51.68M	-48.64M	-40.12M	20.05M	10.62M	13.67M	-6.42M
Net Profit Margin	0.0%	-4.9%	-1.3%	-3.3%	7.8%	6.8%	8.0%	2.1%
EBITDA	324.94M	45.40M	251.60M	192.25M	222.54M	193.01M	184.28M	96.35M
EBITDA Margin	14.6%	1.9%	11.1%	8.4%	16.9%	15.2%	14.6%	6.9%
Depreciation & Amortization	217.99M	2.44M	228.77M	235.15M	99.29M	94.85M	76.92M	74.73M
EPS Basic	0.03	-4.83	-1.23	-3.11	4.86	4.16	4.90	1.33
EPS Diluted	0.03	-4.83	-1.23	-3.11	4.74	4.02	4.69	1.33
Weighted Average Basic Shares	24.64M	24.39M	24.09M	23.87M	21.21M	20.91M	20.63M	21.60M
Weighted Average Diluted Shares	24.90M	24.39M	24.09M	23.87M	21.78M	21.59M	21.55M	21.60M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.